Search Within

Lisa Bodei

  1. "2022"
Formats
  1. Meeting Abstract (4)
  2. Book Section (3)
  3. Guidelines (3)
  4. Journal Article (3)
  5. Review (3)
Groups
  1. Molecular Imaging and Therapy Service (16)
  2. Radiology, Department of (16)
  3. Sloan Kettering Institute Postdocs (16)
  4. Center for Pancreatic Cancer Research (5)
  5. Department of Medicine (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. Heiko Schoder (5)
  2. Diane Reidy (3)
  3. Nitya Raj (3)
  4. Ryan Reddy (3)
  5. Christopher Riedl (2)
  6. Jason Lewis (2)

More People

Years
  1. 2022 (16)
Publications
  1. Pancreas (3)
  2. Journal of Neuroendocrinology (2)
  3. Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (2)
  4. American Journal of Clinical Oncology (1)
  5. American Journal of Roentgenology (1)
  6. Clinical Nuclear Medicine (1)

More Publications

Publishers
  1. Lippincott Williams & Wilkins (5)
  2. Springer (3)
  3. Wiley Blackwell (2)
  4. American Roentgen Ray Society (1)
  5. Elsevier Inc. (1)
  6. National Academy of Sciences (1)

More Publishers

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diagnostic applications of nuclear medicine: Neuroendocrine tumors
    Book Section

    Bodei, L.; Jayaprakasam, V. S.; Kidd, M.; Gilardi, L.; Volterrani, D.; Paganelli, G.; Grana, C. M.; Modlin, I. M.
    In Volterrani, D.; Erba, P. A.; Strauss, H. W.; Mariani, G.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (2022)

    Fulltext@MSK | Save
  • Neuroendocrine tumors: Therapy with radiolabeled peptides
    Book Section

    Bodei, L.; Jayaprakasam, V. S.; Kidd, M.; Gilardi, L.; Volterrani, D.; Paganelli, G.; Grana, C. M.; Modlin, I. M.
    In Volterrani, D.; Erba, P. A.; Strauss, H. W.; Mariani, G.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (2022)

    Fulltext@MSK | Save
  • Clinical and scientific considerations of genomics and metabolomics in radionuclide therapy
    Book Section

    Bodei, L.; Kidd, M.; Modlin, I. M.
    In Signore, A. (Eds.) Nuclear Medicine and Molecular Imaging (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to lutetium-177-DOTATATE
    Journal Article

    Raj, N.; Coffman, K.; Le, T.; Do, R. K. G.; Rafailov, J.; Choi, Y.; Chou, J. F.; Capanu, M.; Dunphy, M.; Fox, J. J.; more...
    Neuroendocrinology (2022)

    Fulltext@MSK | Save
  • The quest for an accurate functional tumor volume with (68)Ga-DOTATATE PET/CT
    Journal Article

    Reddy, R. P.; Schmidtlein, C. R.; Giancipoli, R. G.; Mauguen, A.; LaFontaine, D.; Schoder, H.; Bodei, L.
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • The phase 3 NETTER-1 study of (177)Lu-DOTATATE in patients with midgut neuroendocrine tumors: Updated progression-free survival analyses
    Meeting Abstract

    Kunz, P. L.; Benson, A.; Bodei, L.; Grande, E.; Mittra, E.; Kulke, M. H.; Yao, J. C.; Wolin, E. M.; Niepel, D.; Demange, A.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated (WD) high-grade (HG) neuroendocrine tumors (NETs) to (177)Lu-DOTATATE
    Meeting Abstract

    Coffman, K.; Bodei, L.; Le, T.; Choi, Y.; Chou, J.; Capanu, M.; Dunphy, M.; Fox, J.; Grewal, R.; Reddy, R.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Blood-based genomic assessment of clinical efficacy and toxicity of (177)Lu-DOTATATE of neuroendocrine tumors
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, K. G.; Krebs, S.; Reidy-Lagunes, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schöder, H.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Radiotheranostics in oncology: Current challenges and emerging opportunities
    Review

    Bodei, L.; Herrmann, K.; Schöder, H.; Scott, A. M.; Lewis, J. S.
    Nature Reviews Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
    Journal Article

    Korsen, J. A.; Gutierrez, J. A.; Tully, K. M.; Carter, L. M.; Samuels, Z. V.; Khitrov, S.; Poirier, J. T.; Rudin, C. M.; Chen, Y.; Morris, M. J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2022)

    Fulltext@MSK | Save